Tempus Finds Tumor-Normal Sequencing, RNA Profiling Aid Patient Matching to Therapies, Trials Published on Sep 30, 2019  Triple-Negative Breast Cancer Classification From Whole-Genome Sequencing Can Inform Treatment Published on Sep 30, 2019  Netherlands Drug Repurposing, Tumor Profiling Trial Results Reported at ESMO Published on Sep 30, 2019  PathogenDx Lands $7.5M in Series B Funding Published on Sep 30, 2019  Sciex, Protein Metrics Partner on Mass Spec Data Analysis Published on Sep 30, 2019  Nasdaq Warns Biocept Over Listing Requirement Published on Sep 30, 2019

Featured in Depth

Q&A: BARDA Director Rick Bright Discusses New Programs, Focus on Diagnostics Published on Sep 30, 2019

Carcinoma of Unknown Primary Investigators Pursue Molecular Targets to Tailor Treatments Published on Sep 30, 2019

At HUPO 2019 Proteomics Looks to Solidify Its Place in Broader Research World Published on Sep 27, 2019

UCLA Team Using Electrochemical Liquid Biopsy for Placental Testing Under New NIH Grant Published on Sep 27, 2019

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay This white paper from Thermo Fisher describes an analytical validation of the Oncomine Pan-Cancer Cell-Free Assay using both commercially available pre-characterized cell-free reference materials as well as clinical plasma samples from three solid tumor indications procured from a commercial biorepository. Download it from GenomeWeb’s White Paper Channel.

Recommended for You

Ancient DNA Studies Untangle Genetic History of Indus River Valley Civilization Published on Sep 05, 2019  SkylineDx Secures $21.9M Investment Published on Sep 03, 2019

Temperature-Driven Nucleic Acid Extractions: Faster Results, Timely Decisions Watch this webinar from MicroGEM to discover how to use enzymes derived from nature’s most extreme organisms to extract high-quality DNA and RNA from limited samples (from a single cell to thousands of cells) very quickly and at a reasonable cost. Download it from GenomeWeb’s Webinar library